Phenotype Matching of Donor Red Blood Cell Units for Nonalloimmunized Sickle Cell Disease Patients: A Survey of 1182 North American Laboratories
Authors:
Open Access
- 1 February 2005
- journal article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 129 (2) , 190-193
Abstract
Context. —The transfusion of donor red blood cell units (RBCs) that lack certain red cell antigens (such as C, E, and K) when the corresponding antigens are absent from the recipient's red cells has been shown to reduce the risk of red cell alloimmunization in sickle cell disease patients. However, data are limited regarding the extent to which transfusion services routinely perform red cell antigen phenotype testing of nonalloimmunized sickle cell disease patients, and then use that information to select donor RBCs lacking 1 or more of the red cell antigens that the patient's red cells do not express. Objective. —To determine the extent to which transfusion services routinely perform red cell antigen phenotype testing of nonalloimmunized sickle cell disease patients, and then use that information to select donor RBCs lacking 1 or more of the red cell antigens that the patient's red cells do not express. Design. —An educational subsection of a College of American Pathologists Proficiency Testing Survey (J-C 2003) assessed transfusion service practices regarding performance of red cell antigen phenotype testing of nonalloimmunized sickle cell disease patients and how transfusion services use this information for the selection of donor RBCs. The data analysis of the survey included 1182 North American laboratories. Results. —Data from 1182 laboratories were included in the survey analysis, of which the majority (n = 743) reported that they did not routinely perform phenotype testing of sickle cell disease patients for antigens other than ABO and D. The other 439 laboratories reported that they did routinely perform phenotype testing of sickle cell disease patients for antigens in addition to ABO and D. The majority of these 439 laboratories (three fourths; n = 330) reported that they used these patient data for prophylactic matching with donor RBCs when sickle cell disease patients required transfusion. When phenotype-matched donor RBCs were used, the antigens most commonly matched (85% of the time) were C, E, and K. Conclusions. —The majority of North American hospital transfusion service laboratories do not determine the red cell antigen phenotype of nonalloimmunized sickle cell disease patients beyond ABO and D. Those laboratories that do determine the red cell phenotype of nonalloimmunized sickle cell disease patients beyond ABO and D most commonly match for C, E, and K antigens when phenotype-matched donor RBCs are used.Keywords
This publication has 10 references indexed in Scilit:
- Pre‐transfusion phenotype matching for sickle cell disease patientsTransfusion, 2004
- Managing sickle cell diseaseBMJ, 2003
- Predicting the effect of transfusing only phenotype‐matched RBCs to patients with sickle cell disease: theoretical and practical implicationsTransfusion, 2002
- Prospective RBC phenotype matching in a stroke‐prevention trial in sickle cell anemia: a multicenter transfusion trialTransfusion, 2001
- Financial analysis of chronic transfusion for stroke prevention in sickle cell diseaseBlood, 2000
- To match or not to match: the question for chronically transfused patients with sickle cell anemiaTransfusion, 1994
- Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell DiseaseBlood, 1990
- Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched BloodNew England Journal of Medicine, 1990
- Red cell alloimmunization in sickle cell diseaseBritish Journal of Haematology, 1986
- Post‐transfusion alloimmunization in patients with sickle cell diseaseAmerican Journal of Hematology, 1978